tradingkey.logo
tradingkey.logo
Search

Merit Medical Systems Inc

MMSI
Add to Watchlist
67.230USD
+1.990+3.05%
Close 06/18, 16:00ETQuotes delayed by 15 min
4.00BMarket Cap
28.62P/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-17
Previous score
8.36
Change
0
The current earnings forecast score of Merit Medical Systems Inc is 8.36, ranking 48 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 104.00, with a high of 122.00 and a low of 90.00.

Analyst Rating

Based on 11 analysts
Buy
Current Rating
91.182
Target Price
+36.21%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Merit Medical Systems Inc
MMSI
11
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is Merit Medical Systems Inc's expected revenue for the next quarter?

Merit Medical Systems Inc's expected revenue is 405.53M.

What is Merit Medical Systems Inc's price target?

Analysts forecast that Merit Medical Systems Inc's price target is USD 104.00, with the highest forecast at USD 122.00 and the lowest forecast at USD 90.00.

How have Merit Medical Systems IncMMSI's recent earnings per share performed?

The market expectation was USD 0.69, while Merit Medical Systems IncMMSI's earnings per share (EPS) for the previous quarter was USD 0.64. EPS for the next quarter is expected at USD 0.97.

What is the analyst rating for Merit Medical Systems Inc?

Based on the ratings of Merit Medical Systems Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI